Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Mr. Forthright who wrote (2529)	7/4/1998 10:22:00 PM
From: Mongo2116	Read Replies (5) \| Respond to of 5402

Only a conceited, bigheaded, bag of wind would post the following: Did you post this M.F.? When I first started reading SI I realized that if the profile of the average SI member was similar to the profile of the average American stock buyer, this market was in trouble. This country's economy has been built by long-term strategically thinking entrepreneurs, not by the unsophisticated short-term greedy investor that is so prevalent on the internet. In one of the books I have read many years ago I found a description of today's average investor: "I never hesitate to tell a man that I am bullish or bearish. But I do not tell people to buy or sell any particular stock...But the average man doesn't wish to be told it is a bull or bear market. What he desires is to be told specifically which stock to buy or sell. HE WANTS TO GET SOMETHING FOR NOTHING. HE DOES NOT WISH TO WORK. HE DOESN'T EVEN WISH TO HAVE TO THINK. IT IS TOO MUCH BOTHER TO HAVE TO COUNT THE MONEY THAT HE PICKS UP FROM THE GROUND."

To: Mr. Forthright who wrote (2529)	7/5/1998 4:00:00 PM
From: Turboe	Read Replies (2) \| Respond to of 5402

All right-- let's go with step #1-2 and use this: "Sanguine estimates the annual worldwide market potential for this product at $20 billion. In the United States alone nearly everyone who reaches the age of 75 will need blood, plasma, or one of their components at least once in his lifetime." Drees, who has been in the forefront of the artificial blood products field for more than 20 years, was the president and CEO of the only company to have obtained FDA approval for a synthetic blood product to date. So $20,000,000,000.00 for this product-- annually>.